We came across a bullish thesis on Bristol-Myers Squibb Company on Disruptive Analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY. Bristol-Myers Squibb Company's share was trading at $55.05 as of January 30th. BMY’s trailing and forward P/E were 18.28 and 9.09, respectively according to Yahoo Finance.
[caption id="attachment_400243" align="aligncenter" width="750"]Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.